Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Earlier in December 2025, Recursion Pharmaceuticals reported positive Phase 1b/2 TUPELO trial data for REC-4881 in familial adenomatous polyposis, showing rapid and durable reductions in polyp burden ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is among the best fundamentally strong penny stocks to buy according to analysts. On December 19, TheFly reported that Cathie Wood’s ARK Investment has ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is among the best NASDAQ stocks under $10 to buy. As of December 15, Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) has a ‘Hold’ or equivalent rating from ...

Recursion Pharmaceuticals (NASDAQ: RXRX) experienced an 11% increase in stock price on Wednesday after JP Morgan raised its rating, noting the promising potential of its MEK inhibitor program. However ...

Bun 1.3 revolutionizes full-stack JavaScript development with unified database APIs and zero-config frontend setup.

Belgium has formally joined the case launched by South Africa at the International Court of Justice (ICJ) alleging Israel is committing genocide in the Gaza Strip. In a statement on Tuesday, the ICJ – ...

JPMorgan upgraded Recursion Pharmaceuticals (RXRX) to Overweight from Neutral with a price target of $11, up from $10. The firm says the company’s REC-4881 has shown “strong and durable” efficacy in ...

South Africa initially brought the accusation against Israel before the court over alleged violations of the Genocide Convention in relation to the war in Gaza in December 2023. Belgium has officially ...

Netflix is kicking off 2026 with a mix of new and returning titles set to hit the platform in January. The most highly anticipated title arriving this January is the fourth season of “Bridgerton,” ...